Recalls

210 topics in this forum

1. Vascular Cannula Recall: Medtronic Removes Aortic Root Cannula Due to Unexpected Loose Material in the Male Luer

   By FDA Recalls, March 31
   • 0 replies
   • 80 views
   • 
   • FDA Recalls
   • March 31

3. Safe Use of Megadyne Mega 2000 and Mega Soft Patient Return Electrodes - Letter to Health Care Providers

   By FDA Recalls, March 26
   • 0 replies
   • 72 views
   • 
   • FDA Recalls
   • March 26

4. Endotracheal Tube Recall: Smiths Medical Removes Intubation ORAL/NASAL Endotracheal Tubes Due to Smaller Than Expected Tube Diameter That May Cause Underventilation

   By FDA Recalls, March 25
   • 0 replies
   • 130 views
   • 
   • FDA Recalls
   • March 25

5. Update on Alert: Atherectomy Catheter System Issue from Bard Peripheral Vascular

   By FDA Recalls, March 20
   • 0 replies
   • 106 views
   • 
   • FDA Recalls
   • March 20

6. Infusion Pump Software Correction: Becton, Dickinson and Company (BD) Issues Correction for BD Alaris Systems Manager and Care Coordination Engine Infusion Adapter Software Due to Risk for Outdated Automated Programming Requests to Load

   By FDA Recalls, March 20
   • 0 replies
   • 69 views
   • 
   • FDA Recalls
   • March 20

7. Early Alert: Aspiration System Issue from Calyxo

   By FDA Recalls, March 20
   • 0 replies
   • 154 views
   • 
   • FDA Recalls
   • March 20

8. Update on Alert: Infusion Pump Issue from Baxter Healthcare Corporation

   By FDA Recalls, March 20
   • 0 replies
   • 80 views
   • 
   • FDA Recalls
   • March 20

9. Implantable Port Recall: Smiths Medical Removes ProPort Plastic Implantable Ports Due to Manufacturing Error that May Cause Separation

   By FDA Recalls, March 19
   • 0 replies
   • 124 views
   • 
   • FDA Recalls
   • March 19

10. Embolization Device Recall and Correction: Medtronic Removes Unused 027 Compatible Pipeline Vantage Embolization Device with Shield Technology, Updates Use Instructions for 021 Compatible Pipeline Vantage Embolization Devices due to Increased Risk of Inco

    By FDA Recalls, March 18
    • 0 replies
    • 65 views
    • 
    • FDA Recalls
    • March 18

11. Disruptions in Availability of Hemodialysis Bloodlines - Letter to Health Care Providers

    By FDA Recalls, March 14
    • 0 replies
    • 138 views
    • 
    • FDA Recalls
    • March 14

12. Dr. Reddy’s Issues a Nationwide Recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, in the U.S., Due to Mislabeling of Infusion Bag

    By FDA Recalls, March 13
    • 0 replies
    • 79 views
    • 
    • FDA Recalls
    • March 13

13. Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC): Voluntary Lot Withdrawals - Due to Increased Reports of Allergic/Hypersensitivity Reactions

    By FDA Recalls, March 11
    • 0 replies
    • 83 views
    • 
    • FDA Recalls
    • March 11

14. Smiths Medical Issues Urgent Medical Device Correction Informing Customers of a Potential Issue with Certain Sizes of Intubation ORAL/NASAL Endotracheal Tubes Being Smaller Than Expected

    By FDA Recalls, March 10
    • 0 replies
    • 129 views
    • 
    • FDA Recalls
    • March 10

15. Early Alert: Infusion Pump Issue from Baxter Healthcare Corporation

    By FDA Recalls, March 5
    • 0 replies
    • 131 views
    • 
    • FDA Recalls
    • March 5

16. Update on Alert: Solution Set Issue from Baxter Healthcare Corporation

    By FDA Recalls, March 5
    • 0 replies
    • 96 views
    • 
    • FDA Recalls
    • March 5

17. Update on Alert: Infusion Pump Software Issue from Fresenius Kabi USA

    By FDA Recalls, March 5
    • 0 replies
    • 115 views
    • 
    • FDA Recalls
    • March 5

18. Endovascular System Recall: Philips Removes and Discontinues Distribution of Tack Endovascular System Due to User Challenges That Caused Additional Procedures to Reposition or Remove Implant

    By FDA Recalls, March 3
    • 0 replies
    • 88 views
    • 
    • FDA Recalls
    • March 3

19. One Source Nutrition, Inc. Issues Voluntary Nationwide Recall of Vitality Capsules Due to Presence of Undeclared Sildenafil and Tadalafil

    By FDA Recalls, March 3
    • 0 replies
    • 104 views
    • 
    • FDA Recalls
    • March 3

20. Vaporizer Recall: Getinge Removes Vaporizer Sevoflurane Quick-Fil and Expands Recall of Vaporizer Sevoflurane Maquet Filling due to Risk of Patient and Health Care Professional Exposure to Toxic Chemical Hydrogen Fluoride

    By FDA Recalls, March 3
    • 0 replies
    • 77 views
    • 
    • FDA Recalls
    • March 3

21. Power Assist Device Recall: Max Mobility/Permobil Removes SpeedControl Dial Component Used with SmartDrive MX2+ Power Assist Device Due to Risk for Motor to Be Unresponsive to the User

    By FDA Recalls, March 2
    • 0 replies
    • 71 views
    • 
    • FDA Recalls
    • March 2

22. Patient Table Correction: Philips Updates Use Instructions for Allura and Azurion Systems due to Patient Fall Risk from Incorrectly Positioned Mattresses

    By FDA Recalls, February 28
    • 0 replies
    • 77 views
    • 
    • FDA Recalls
    • February 28

23. Ablation Catheter Correction: Biosense Webster Updates Use Instructions for Varipulse due to High Rate of Stroke or Transient Ischemic Attack

    By FDA Recalls, February 28
    • 0 replies
    • 118 views
    • 
    • FDA Recalls
    • February 28

24. Endoscope Instrument Recall: Olympus Removes Single Use Guide Sheath Kits Due to Risk for Radiopaque Guide Sheath Tip Detaching During Procedures

    By FDA Recalls, February 28
    • 0 replies
    • 91 views
    • 
    • FDA Recalls
    • February 28

25. Regard Newborn Kit Recall: ROi CPS, LLC Removes Certain Newborn Kits Due to a Recalled Component, the Neo-Tee T-Piece Resuscitator With An Undersized Controller Spring

    By FDA Recalls, February 28
    • 0 replies
    • 92 views
    • 
    • FDA Recalls
    • February 28

26. Natural Dior LLC Issues Voluntary Nationwide Recall of Vitafer-L Gold Liquid Due to Presence of Undeclared Tadalafil

    By FDA Recalls, February 26
    • 0 replies
    • 89 views
    • 
    • FDA Recalls
    • February 26